What is the management and prognosis of breath holding spells in infants and young children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Breath-Holding Spells: Management and Prognosis

Definition and Clinical Recognition

Breath-holding spells are benign, self-limited events in young children (typically 6 months to 5 years) that require parental reassurance as the cornerstone of management, with iron supplementation for those with deficiency and consideration of midodrine or cardiac pacing only for severe, refractory cases. 1, 2

Breath-holding spells represent a brief involuntary cessation of breathing at end-expiration in response to emotional or painful stimuli, affecting 0.1-4.6% of otherwise healthy children with peak onset between 6-18 months of age. 3, 4 These episodes are distinct from voluntary breath-holding and represent either:

  • Cyanotic type: Triggered by anger/frustration, characterized by crying followed by forced expiratory apnea, cyanosis, rigidity or limpness, and brief loss of consciousness (10-60 seconds). 4, 5
  • Pallid type: Triggered by pain/fear, representing cardioinhibitory vasovagal syncope with minimal crying, brief apnea, pallor, and loss of consciousness due to vagally-mediated cardiac inhibition. 3, 5

Diagnostic Approach

Obtain a detailed history focusing on triggers, sequence of events, color changes, and family history, combined with a standard 12-lead ECG to exclude long QT syndrome—this is sufficient for diagnosis in most cases. 1, 2

Essential History Elements:

  • Precipitating factors (emotional upset, pain, fear) 1
  • Sequence: trigger → crying → breath-holding → color change → loss of consciousness → spontaneous resolution 4
  • Duration (typically <1 minute, with 78% lasting <60 seconds) 6
  • Presence of seizure-like activity (occurs in 71.5% due to cerebral hypoxia, not epilepsy) 6
  • Family history of syncope or sudden cardiac death 3

Physical Examination and Testing:

  • 12-lead ECG is mandatory to exclude long QT syndrome, Brugada syndrome, and other channelopathies. 3, 1
  • EEG is NOT routinely indicated—only 3.8% show pathology, and most of these have concomitant epilepsy unrelated to breath-holding spells. 6
  • Hemoglobin/iron studies if considering iron supplementation 1

Critical pitfall: Do not confuse these benign spells with cardiac syncope. Red flags requiring extensive cardiac evaluation include: syncope during exercise, syncope while supine, absence of prodromal symptoms, family history of sudden death <30 years, or abnormal ECG. 3

Management Algorithm

First-Line: Parental Education and Reassurance

Confident reassurance and frank explanation are the cornerstones of treatment, as these spells are benign with spontaneous resolution by age 5 years in the vast majority of cases. 4, 5

  • Teach proper positioning during episodes (recovery position) to prevent injury 1
  • Instruct parents to stay with the child, avoid restraint, and never place anything in the mouth 1
  • Explain the benign nature and excellent prognosis without adverse developmental or intellectual sequelae 5
  • Activate emergency services only if seizure activity lasts >5 minutes 1

Second-Line: Iron Supplementation

For children with iron deficiency (hemoglobin <10 g/dL), provide iron supplementation, which reduces frequency and severity of spells. 1, 2

This intervention is supported by the American College of Cardiology and has demonstrated effectiveness in reducing spell frequency. 1

Third-Line: Pharmacological Intervention for Severe Cases

For persistent, severe cases (≥4 spells/week) not responding to reassurance and iron supplementation, consider midodrine therapy, which reduces recurrence rates from 80% to 22%. 1, 2

Alternative pharmacological options for severe cases include:

  • Piracetam (50-100 mg/kg/day): 81% complete resolution in one study, though this is not widely adopted in US guidelines 7
  • Valproic acid (5 mg/kg/day): Showed effectiveness in reducing cyanotic spell frequency, possibly through mood stabilization 8

Critical caveat: Beta-blockers are contraindicated—they may actually increase recurrence rates in pediatric vasovagal syncope and can worsen bradycardia in cardioinhibitory cases. 3, 2

Fourth-Line: Cardiac Pacing (Rare)

Cardiac pacing may be considered for severe pallid breath-holding spells with documented prolonged asystole, with 86% of patients experiencing complete resolution or significant reduction in syncopal events. 1, 2

However, approach this cautiously given:

  • Potential long-term complications of pacing in young children 2
  • Natural resolution with age in most cases 2
  • Need for documented asystole before consideration 3, 1

Prognosis

The prognosis is excellent—breath-holding spells typically resolve spontaneously by age 5 years without adverse developmental, intellectual, or cardiac sequelae. 4, 5

While rare complications including status epilepticus, prolonged asystole, and sudden death have been reported in the literature, these are exceptional cases. 5 The vast majority of children experience complete resolution without intervention beyond parental reassurance. 3, 4

Important distinction: These benign spells must be differentiated from cardiac syncope, which carries significant mortality risk when associated with underlying heart disease, structural abnormalities, or channelopathies. 3

References

Guideline

Approach and Treatment for Breath-Holding Spells with Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Breath-Holding Spells in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Piracetam in severe breath holding spells.

International journal of psychiatry in medicine, 2008

Related Questions

What is the management and prognosis of breath holding spells in infants and young children?
What is the treatment for breath holding spells in children?
What is the management approach for children experiencing breath holding spells or seizures?
What is the approach and treatment for a child experiencing breath holding spells with seizures?
What is the appropriate management for an infant experiencing breath-holding spells, particularly if they have a history of respiratory or neurological conditions?
What is the management approach for re-expansion pulmonary edema in a patient with a history of lung disease or significant pneumothorax?
What is the recommended dosage of ceftriaxone for a patient with variceal bleeding in the digestive tract, considering liver disease?
What to do about frequent nose bleeds in an adult with atrial fibrillation and a history of cardiovascular disease, currently on apixaban (Apixaban) and Aspirin (Acetylsalicylic Acid, ASA)?
What causes a retention cyst in the brain?
How long should a patient with a history of taking aspirin (acetylsalicylic acid) hold their medication before undergoing cataract extraction?
Can a female patient with a history of persistent dry cough, deviated septum, and chronic lower back pain, who is currently taking Singulair (montelukast), Flonase (fluticasone), Claritin (loratadine), Astelin (azelastine), Nasacort (triamcinolone), Breztri (budesonide, glycopyrrolate, formoterol), Albuterol (salbutamol), and Tussionex (hydrocodone, chlorpheniramine), and has tried Panteprazole (proton pump inhibitor) and Omneprazole (proton pump inhibitor) for ruled-out GERD (gastroesophageal reflux disease), and has undergone physical therapy for degenerative disc disease, be treated with a single medication for both conditions, and should any of her current medications be discontinued due to polypharmacy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.